As the ASX200 edges higher with positive investor sentiment, the Materials sector leads the charge, followed closely by Financials and Telecommunications. In this environment, identifying undervalued stocks becomes crucial for investors looking to capitalize on potential growth opportunities amidst fluctuating sector performances.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Vysarn (ASX:VYS) | A$0.52 | A$0.98 | 47.1% |
Reckon (ASX:RKN) | A$0.655 | A$1.18 | 44.7% |
PointsBet Holdings (ASX:PBH) | A$1.26 | A$2.14 | 41.1% |
Fenix Resources (ASX:FEX) | A$0.305 | A$0.51 | 39.9% |
Elders (ASX:ELD) | A$7.55 | A$14.04 | 46.2% |
Collins Foods (ASX:CKF) | A$9.35 | A$16.20 | 42.3% |
Charter Hall Group (ASX:CHC) | A$21.70 | A$36.21 | 40.1% |
Austal (ASX:ASB) | A$6.86 | A$13.11 | 47.7% |
archTIS (ASX:AR9) | A$0.21 | A$0.41 | 48.3% |
Advanced Braking Technology (ASX:ABV) | A$0.10 | A$0.16 | 39.3% |
Click here to see the full list of 31 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
Overview: Capricorn Metals Ltd is involved in the evaluation, exploration, development, and production of gold properties in Australia with a market cap of A$4.24 billion.
Operations: The company's revenue primarily comes from its Karlawinda gold operations, generating A$379.47 million.
Estimated Discount To Fair Value: 36.8%
Capricorn Metals appears undervalued, trading at A$9.83 against an estimated fair value of A$15.54, a 36.8% discount. The company recently repaid its $50 million debt early, supported by strong cash flows and $405 million in cash and bullion holdings as of March 2025. With earnings forecasted to grow significantly at 24.73% annually, outpacing the Australian market's growth rate of 10.9%, Capricorn is well-positioned for future expansion projects like Karlawinda and Mt Gibson Gold Projects.
Overview: Nanosonics Limited is a global infection prevention company with a market capitalization of A$1.21 billion.
Operations: The company's revenue is primarily derived from its Healthcare Equipment segment, totaling A$183.97 million.
Estimated Discount To Fair Value: 22.5%
Nanosonics is currently trading at A$4, below its estimated fair value of A$5.16, reflecting a discount of over 20%. Despite a low forecasted return on equity of 13.9% in three years, earnings are projected to grow significantly at 22.9% annually, surpassing the Australian market's growth rate. Revenue growth is expected to be 9.6% per year, also outpacing the broader market's rate of 5.6%, highlighting potential for continued business expansion supported by cash flows.
Overview: Nick Scali Limited, with a market cap of A$1.75 billion, operates in the sourcing and retailing of household furniture and related accessories across Australia, New Zealand, and the United Kingdom.
Operations: The company's revenue is primarily generated from the retailing of furniture, amounting to A$495.28 million.
Estimated Discount To Fair Value: 39.3%
Nick Scali is trading at A$20.51, significantly below its estimated fair value of A$33.76, indicating it is undervalued by more than 20%. Despite a decline in net income to A$57.68 million from the previous year's A$80.61 million, revenue growth is forecasted at 9% annually, outpacing the Australian market's 5.6%. Although profit margins have decreased to 11.6%, earnings are expected to grow faster than the market at 17% per year.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.